Weight-Loss surgery patients may get bone protection from common osteoporosis drug
NCT ID NCT04922333
First seen Jan 05, 2026 · Last updated May 14, 2026 · Updated 15 times
Summary
This study tests whether a monthly pill called risedronate can prevent bone and muscle loss that often happens after weight-loss surgery. About 200 adults who have had sleeve gastrectomy will take either risedronate or a placebo for 6 months and be followed for a year. Risedronate is already FDA-approved for osteoporosis but not for this use. The goal is to see if it helps keep bones strong after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE LOSS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wake Forest School of Medicine
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.